CYP2D6 Metabolizer Status Does Not Predict Response or Tolerability of Low-Dose Nortriptyline for Irritable Bowel Syndrome With Diarrhea.

Authors

Kyle Staller, Jenna Clukey, Elizabeth N Madva, Brian C Healy, Minyi Lee, Manish K Gala

Published in

Gastro hep advances. Volume 5. Issue 12. Pages 101111. Epub Sep 01, 2026.

PMID:
42831162
Bibliographic data and abstract were imported from PubMed on 05 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.